Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
232
Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

- POAI subsidiary inks contract with significant pharmaceutical company
- TumorGenesis announces sale of media to research medical centers in New York City, Boston
- Potential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech, recently inked another contract with a large pharmaceutical company (https://nnw.fm/8oxui). POAI also announced that TumorGenesis, one of its wholly owned subsidiaries, has sold media to two top research medical centers (https://nnw.fm/IxIis).

Soluble Biotech’s contract will involve using the company’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destined for future clinical use.

“This opportunity may also lead to a long-term relationship whereby Soluble Biotech develops a strategic partnership to support several other therapeutics currently under development within the pharmaceutical company,” said Soluble Biotech Founder and President Dr. Larry DeLucas.

In additional company news, Predictive Oncology shared details about the sale of media to two top research medical centers. The sales by TumorGenesis, POAI’s wholly owned subsidiary, were repeat orders from hospitals in New York City and Boston, and included culturing ovarian cancer cells with specific research goals.

“We believe that this is the future of ovarian cancer research, which creates new possibilities to coming up with new treatments for this chronic and deadly disease,” said Predictive Oncology President and CEO Dr. Carl Schwartz. “In order for us to find better drugs, we have to be able to grow the right patient cells in the right media. Building the ‘living library’ of cancer cells for drug screening and discovery is the right first step.” POAI is committed to this first step and is the process of building the largest existing database of drug response data in the world.

The announcement noted that TumorGenesis can replicate ovarian cancer cells in a laboratory—outside of the patient’s body. The company has 15 ovarian cancer cell lines along with the media to grow those cells.

“These tissues, in the right TumorGenesis media, replicate not only the DNA/RNA and proteomic signatures but also replicate the histological structures that can be seen in staining, outside the patient’s body,” said TumorGenesis President and board member Richard Gabriel. The process produces invaluable information that can be used by oncologists and other cancer treatment experts to potentially identify and prescribe treatments and care for cancer patients, resulting in more positive outcomes.

The potential market for what POAI does — 3D cancer cell culture media — is expected to reach $3.2 billion sales worldwide by 2027. The space is so explosive because it currently offers the best available models for cancer drug discovery and development.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of more than 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Predictive Oncology Inc. (POAI) Stock Research Links

POAI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 278

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 181

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 194

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 137

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 201

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 202

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

FarmHouse Fresh Celebrates 20 Years of Skincare Innovation

Updated Category News Views 294

Celebrating Two Decades of Skincare Excellence FarmHouse Fresh® is excited to celebrate its 20th anniversary, a significant milestone in its journey of transforming skincare routines and enriching lives through animal rescue. Over the last two decades, the brand has become renowned for its unique farm-to-table skincare products, drawing inspiration from nature's best...

Continue Reading
Rigetti Computing and Quanta Computer Join Forces for Quantum Advancements

Updated Category News Views 437

Exciting Collaboration in Quantum Technology Rigetti Computing, Inc. (NASDAQ: RGTI), a leader in quantum-classical computing, has forged a powerful collaboration with Quanta Computer Inc., a major player based in Taiwan. This strategic agreement signifies a strong commitment from both companies to push the boundaries of superconducting quantum computing, with a shared...

Continue Reading
Crucial Update for Match Group, Inc. Investors: Act Now

Updated Category News Views 189

Update on Match Group, Inc.'s Ongoing Class Action In recent developments, investors holding shares in Match Group, Inc. (NASDAQ: MTCH) are reminded of their rights as a class action has been initiated on behalf of those who purchased or acquired MTCH securities during the designated period. This lawsuit follows significant stockholder losses, particularly pertaining to...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 214

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading
Stock Market Movements: Energy Surges as Instil Bio Drops

Updated Category News Views 144

Stock Market Overview The latest trading session produced varied results for U.S. stocks, creating a mixed bag for investors. The Nasdaq Composite dipped by about 1%. In contrast, the Dow Jones Industrial Average rose by 0.29%, reaching a noteworthy 41,512.19. On the other hand, the S&P 500 experienced a slight decline of 0.24%, settling at 5,612.35. Sector Performance...

Continue Reading